Summary.-A simple method of calculating the best ages for carrying out cervical cytology screening procedures is proposed. The argument is graphical, the outcomes are readily understood by visual and intuitive methods, but a computer program for assisting the calculations is constructed. Use of the method indicates that relatively high rates of screening should be employed in women over 45, and that routine screening in women under 30 years of age is likely to be ineffective in reducing mortality. The method predicts that, if we assume a negative error rate for the test of 0-2, and a natural history with a mean interval between detectability and incurability of about 6 years, a series of 10 tests deployed between 35 and 80 years in England and Wales should give a yield of 0.67 deaths saved per 1000 tests performed, and should be capable of saving about 77%o of all deaths from cervical cancer in women who conform with the recommendation.
FORMULATING the best ages and frequencies for cervical cytology screening requires a knowledge of a range of facts. This includes information on, (a) the onset rates and natural histories (i.e. durations and rates of change) of the various cervical pathologies, and their variations with age, (b) the negative and positive error rates of the cytological test with respect to each of these stages, (c) levels of acceptability in each age group, (d) the effectiveness of treatment at each stage, (e) the cost of the various procedures used and, (f) an assessment of available material and financial resources. With such a range of information it would be possible to calculate the investment necessary to achieve a given (and feasible) level of control, or alternatively, the level of control possible for a given level of investment and mode of deployment. An approach to the necessary computational processes has been presented by the present author (Knox, 1973; 1975) .
Unfortunately, not all this factual material is available: there is disagreement about the error rates, and about the natural histories of dysplasia and carcinoma in situ, in particular. Repetition of the calculations is therefore necessary for each set of alternative " facts ", and the computations are complex and tedious. This is of no great importance when a computer is used, but their complexity removes the procedure from ready intuitive appreciation, and the wide choice of alternative results for alternative premises reduces the precision of the guidance which can be obtained.
The question therefore arises, whether a simplified approach may be able to circumvent some of the uncertainties and differences of opinion, and some of the complexity of the computation, at an acceptable cost. This cost will consist of a loss of detail and comprehensiveness in predicting the con.sequences of proposed policies, but it might be possible to hold the costs at an acceptable level while providing an adequate interim statement of an optimal strategy. The development, demonstration and usage of a simplified basis for this process is the purpose for the present paper.
Two main simplifications of method are adopted in this approach.
First simplification
The first simplification is the abandonment of any consideration of acceptability. That is, uncertainty about levels of acceptance at different ages, is circumvented by assuming that all women in the population will attend. The calculated consequences of proposed policies therefore apply only to those women who act upon the recommendations. Predicting the effect upon total population mortality requires additional computation.
Second simrplification
The second simplification is designed to circumnvent uncertainties and differences of opiniioIn about the proportions of dysplasias aind carcinomas in situ which progress to invasive disease, and the way these proportions may vary with age, between countries, or between laboratories If the main concern were to save lifeyears rather than lives, the curve of mortality could first be multiplied by eo-values, taken from the current female life-table, to give an age-specific curve of life years lost per thousand population per annum, from this disease. Age-specific curves of mortality and of life-years-lost are given in Fig. 3 The results of a cost-effective policy which attempted to relate the age/ frequency of screening to subsequent (i.e. after B + A/2) mortality levels, can be demonstrated visually by a simple graphic method. This is shown in Fig. 4 Fig. 4 is again the "compromise " curve of Fig. 3, based upon (mortality x A/eO). This demonstration refers to a fixed Interval A, and a fixed Interval B, and a more realistic model would repeat the graphical examination for a range of A and B occurring in specified proportions. An adaptation of the graphical techniques for this purpose can be envisaged and may not in practice be prohibitive in time and effort. Nevertheless, it takes only a simple computer program to set up a family of such graphs and to accumulate the effects of a range of age/frequency policies set against a variety of natural histories and a variety of error rates. A program of this simplicity, requiring only simple inputs, and readily understood in visual terms, possibly meets the main objectives of this paper. Such a program was written and is available.
Practical recommendations for England and W1'ales
In England and Wales at the present time about 2-6 million cervical smears are carried out annually (DHSS, 1975 Alteration of the estimate for the negative error rate changed the yield for a given investment but did not substantially alter the optimal age-distribution for the tests. For a negative error rate of 0 I the optimal age-distribution was at ages 33, 40, 44, 48, 51, 54, 61, 75 and 80: 83% of deaths were saved and the yield was 0-71 deaths saved per 1000 tests. When the negative error rate was increased to 0 3 the optimal age distribution turned out at ages 36, 40, 44, 48, 51, 54, 61, 67, 73, 80. The proportion of deaths saved was 71.6% and the yield per 1000 tests was 0-61 deaths saved.
Alterations of the criterion for maximization also resulted in relatively minor changes. Maximization of life years saved per 1000 tests (with a return to the negative error rate estimate of 0.2) resulted in an optimal distribution at ages 35, 40, 44, 48, 51, 54, 59, 66, 73 and 80. 77.8% of deaths were saved and 77.0% of life years. Maximization of weiglhted life years saved per 1000 tests indicated an optimal distribution at ages 35, 40, 44, 48, 51, 54, 61, 68, 75 and 80: exactly the same as for maximization of deaths saved per 1000 tests.
All these results depend upon the assumption of constancy of natural history in women of different ages, and a more complex model, allowing for variation, would certainly give different results. For example, if the retrospective natural history of women who die late in life were longer than that in women who die early, there would be advantages in closing up some of the earlier intervals and reducing the investment at the later ages.
